CN115246791A - Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof - Google Patents

Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof Download PDF

Info

Publication number
CN115246791A
CN115246791A CN202110452469.9A CN202110452469A CN115246791A CN 115246791 A CN115246791 A CN 115246791A CN 202110452469 A CN202110452469 A CN 202110452469A CN 115246791 A CN115246791 A CN 115246791A
Authority
CN
China
Prior art keywords
compound
substituted
base
alkali
unsubstituted alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110452469.9A
Other languages
Chinese (zh)
Inventor
陈邦池
盛秋菊
张洪伟
张天浩
姚波
盛国荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inner Mongolia Shijie Chemical Co ltd
Original Assignee
Sichuan Orlando Chemical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Orlando Chemical Co ltd filed Critical Sichuan Orlando Chemical Co ltd
Priority to CN202110452469.9A priority Critical patent/CN115246791A/en
Publication of CN115246791A publication Critical patent/CN115246791A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • C07C307/06Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms

Abstract

The invention provides a method for synthesizing 6-trifluoromethyl uracil and an intermediate thereof. The method comprises the following steps: reacting an amino compound with a halogenated acetylation reagent under the action of alkali 1 to obtain a compound (I), and performing a second step: reacting the compound (I) obtained in the step one with a compound (II) in a certain solvent under the action of a base 2 to obtain a 6-trifluoromethyl uracil compound, wherein the reaction formula is as follows: the method comprises the following steps:
Figure DDA0003039336150000011
step two:
Figure DDA0003039336150000012
wherein R is 1 Is substituted or unsubstituted alkyl, substituted or unsubstituted aromatic hydrocarbonA nitrogen-containing heterocycle; x is halogen; r 2 Is hydrogen, substituted or unsubstituted alkyl; r 3 Is a substituted or unsubstituted alkyl group. The method can be applied to the preparation of the difenosulfuron, and has the following advantages: simple operation, safe and easily obtained raw materials, mild reaction, high yield and suitability for industrial production.

Description

Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a method for synthesizing 6-trifluoromethyl uracil and an intermediate thereof.
Background
6-trifluoromethyl uracil is an important synthetic intermediate, and can be used for synthesizing agricultural medicines. For example, saflufenacil, developed by basf corporation, is a class of 6-trifluoromethyluracil herbicides (WO 2001083459). Saflufenacil is effective in controlling a variety of weeds in corn, sorghum, soybeans, small grain cereals, cotton and fruit trees, is very safe for crops, and has low volatility, "favorable" toxicology and ecological characteristics. Saflufenacil is known by basf corporation as the most successful new herbicide developed over two decades.
At present, the preparation methods of the 6-trifluoromethyl uracil compounds disclosed in the prior art specifically include the following methods:
patent CN100368392 discloses a preparation method of 6-trifluoromethyl uracil, which is to prepare phenyl isocyanate by reacting an amino intermediate with phosgene, thereby synthesizing uracil. The methods all use highly toxic phosgene, and the intermediate phenyl isocyanate is unstable and easy to generate polymerization side reaction (as shown in a reaction formula), so that the method is not suitable for industrial production.
Figure BDA0003039336140000011
The patent CN1344258 improves the method for synthesizing 6-trifluoromethyl uracil intermediate, and under the action of alkali, the aminomethyl compound reacts with amine compound to prepare 6- (perfluoroalkyl) uracil compound, but the aminomethyl compound as the raw material has safety problem in preparation of flammable sodium-hydrogen compound, and industrial production is not easy to realize.
Figure BDA0003039336140000021
Patent CN101821233 describes a method for synthesizing 6-trifluoromethyl uracil, which utilizes 3-aminobenzenesulfonamide to react with chloroformate, and the product is cyclized with 3-amino acrylate to obtain uracil compound. The method is useful for preparing chloroformate which is highly toxic.
Figure BDA0003039336140000022
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a safe, simple and convenient method for synthesizing 6-trifluoromethyl uracil and an intermediate thereof.
A method for synthesizing 6-trifluoromethyl uracil, the method comprising, step one: the amino compound reacts with a halogenated acetylation reagent under the action of alkali 1 to prepare a compound (I), which is represented by the following reaction formula:
Figure BDA0003039336140000023
wherein, R is 1 Is substituted or unsubstituted alkyl, substituted or unsubstituted aromatic hydrocarbon group, nitrogen-containing heterocycle; x is halogen, preferably chlorine; y is halogen, X 3 CCOO-;
Step two: reacting the compound (I) obtained in the step one with a compound (II) in a certain solvent under the action of a base 2 to obtain a 6-trifluoromethyl uracil compound, wherein the reaction formula is as follows:
Figure BDA0003039336140000031
wherein, R is 1 And X is as defined above;
said R 2 Is substituted or unsubstitutedAn alkyl group.
The base 1 in the first step is an organic base or an inorganic base, such as alkali metal carbonate, trialkylamine, pyridine and the like, and is preferably pyridine;
the solvent in the second step is an aprotic solvent, such as DMF, DMSO, xylene, and preferably DMF;
the alkali 2 in the second step is alkali metal carbonate or nitrogenous organic alkali, preferably potassium carbonate, sodium carbonate, DMAP and the like;
the molar ratio of the compound (II) to the compound (I) is 1-4; in the second step, the molar ratio of the base 2 to the compound (I) is 1 to 4, preferably 2 to 3;
the reaction temperature is 110-150 ℃, preferably 115-130 ℃.
The method for synthesizing 6-trifluoromethyl uracil can be applied to the preparation of the difenosulfuron, and the preparation method comprises the following steps: the amino compound reacts with halogenated acetyl reagent under the action of alkali 1 to prepare a compound (III), which is represented by the following reaction formula:
Figure BDA0003039336140000032
wherein, R is 3 Is composed of
Figure BDA0003039336140000033
Preferably, it is
Figure BDA0003039336140000034
Wherein R is 4 Is hydrogen, substituted or unsubstituted alkyl; r 5 Is hydrogen, substituted or unsubstituted alkyl; r 6 、R 7 Each independently hydrogen, substituted or unsubstituted alkyl; x is halogen, preferably chlorine; y is halogen, X 3 CCO 2 -;
Step two: reacting the compound (III) obtained in the step one with a compound (II) in a certain solvent under the action of a base 2 to obtain a compound (IV), namely the difenosulfuron, which is represented by the following reaction formula:
Figure BDA0003039336140000041
wherein, R is 3 、R 4 、R 5 、R 6 、R 7 And X is as defined above;
r is as described 2 Is substituted or unsubstituted alkyl;
the base 1 in the step one is an organic base or an inorganic base, such as alkali metal carbonate, pyridine, triethylamine and the like, and is preferably pyridine;
the solvent in the second step is an aprotic solvent, such as DMF, DMSO, xylene, preferably DMF;
the alkali 2 in the second step is alkali metal carbonate or nitrogenous organic alkali, preferably potassium carbonate, sodium carbonate, DMAP and the like;
the molar ratio of the compound (II) to the compound (III) is 1-4; the molar ratio of the base 2 to the compound (III) is 1 to 4, preferably 2 to 3;
the reaction temperature is 110-150 ℃, preferably 115-130 ℃.
A compound III having the formula:
Figure BDA0003039336140000042
wherein X is halogen, preferably chlorine; r is 3 Is composed of
Figure BDA0003039336140000043
Preferably a
Figure BDA0003039336140000044
Wherein R is 4 、R 5 、R 6 、R 7 Each independently hydrogen, substituted or unsubstituted alkyl.
The compound is preferably
Figure BDA0003039336140000045
The substituted alkyl or substituted aromatic hydrocarbon group in the invention refers to alkyl or aromatic hydrocarbon group which is substituted by hydrogen atom with one or more substituent groups, wherein the substituent groups are atoms or functional groups. For example, substituents that may be present include, but are not limited to: (C1-C7) alkyl, aryl, heteroaryl, halogen, cyano, nitro, carbonyl, and the like.
Compared with the prior art, the preparation method of 6-trifluoromethyl uracil provided by the invention has the following advantages:
(1) Avoiding the use of highly toxic phosgene and chloroformate compounds. The preferred trichloroacetyl chloride reagent is low in toxicity, safe and easy to obtain, and is suitable for industrial production;
(2) The trichloroacetamide intermediate is stable, and the preparation and use of unstable isocyanate intermediates (highly sensitive to water, self-polymerization and the like) are avoided.
(3) The total reaction yield is high, and the method is suitable for industrial production.
Detailed Description
The following examples further illustrate some of the features of the present invention, but the invention is not limited by the following examples in its content and scope of protection
Example 1:
under the protection of nitrogen, DCM (5 mL), the compound N- (2-chloro-4-fluoro-5-amino-benzoyl) -N '-isopropyl-N' -methylsulfonamide (0.32 g) and pyridine (0.1 g) were sequentially added into a 25mL three-necked flask, stirred and cooled, trichloroacetyl chloride (0.2 g) was added dropwise, the temperature was controlled at 0-5 ℃, and the temperature was maintained until the reaction of the raw materials was completed. Water and DCM were added, the organic layer was washed with water, with aqueous sodium bicarbonate, dried and concentrated to give N- [ 2-chloro-4-fluoro-5- { (trichloroethoxycarbonyl) -amino } benzoyl ] -N '-isopropyl-N' -methylsulfonamide as a yellow solid, 0.46 g.
Nuclear magnetic data of intermediate: 1 H NMR(500MHz,CDCl 3 )δ8.54(d,J=8.0Hz,1H),8.52(s,1H),7.25(d,J=10.0Hz,1H),4.24(dq,J=13.4,6.7Hz,1H),2.90(s,3H),1.16(s,3H),1.15(s,3H).
N 2 under protection, DMF3ml, N- [ 2-chloro-4-fluoro-5- { (trichloroethoxycarbonyl) -amino } benzylAcyl radical]-N '-isopropyl-N' -methylsulfonamide (0.32 g), 3-amino-4, -ethyl trifluorocrotonate (0.366 g), potassium carbonate (0.18 g), reacted at 120 ℃ for 3 hours, cooled to room temperature, added with water and ethyl acetate to react, the aqueous layer was made acidic, extracted with ethyl acetate, the organic layer was washed and concentrated to give 0.28g of a product. The yield thereof was found to be 84%.
Nuclear magnetic data:
1 H NMR(500MHz,DMSO-d6)δ12.83(s,1H),12.28(s,1H),7.83(d,J=9.5Hz,1H),7.78(d,J=7.6Hz,1H),6.46(s,1H),4.10(dq,J=13.3,6.6Hz,1H),2.83(s,3H),1.14(d,J=6.7Hz,6H).
example 2:
N 2 under the protection, 5mL of DCM, the compound para-fluoroaniline (1.11 g) and pyridine (0.87 g) are sequentially added into a reaction flask, stirred and cooled, trichloroacetyl chloride (1.85 g) is added dropwise, and the T is maintained<The reaction is basically completed at the temperature of 8 ℃. DCM and water were added and the organic layer was washed with water, sodium bicarbonate solution, dried and concentrated to give 2.5g of a solid.
Into a reaction flask, 5ml of DMF, the compound N-p-fluorophenyl trichloroacetamide (0.5 g), and ethyl 3-amino-4, 4-trifluorocrotonate (0.73 g), sodium carbonate (0.5 g), N 2 Under protection, heating to 130 ℃, reacting for 2h, cooling, adding water and ethyl acetate for extraction, adjusting the water layer to acidity, extracting with ethyl acetate, washing the organic layer, and concentrating to obtain 0.43g of product with the yield of 80%.
Nuclear magnetic data: 1 H NMR(500MHz,DMSO-d6)δ12.51(s,1H),7.38–7.33(m,2H),7.30(dd,J=12.2,5.5Hz,2H),6.35(s,1H).
example 3:
DCM (25 ml), n-butylamine (5 g) and pyridine (6.45 g) are added into a 100ml three-neck flask in sequence under the protection of nitrogen, the temperature is reduced to 0-5 ℃ by stirring, then trichloroacetyl chloride (14.8 g) is added dropwise, the temperature is controlled to 0-5 ℃ until the raw materials react completely. Water and DCM were added to the reaction system, washed with water by layers, washed with sodium bicarbonate solution, dried and concentrated to give 14.2g of yellow liquid N-trichloroacetyln-butylamine.
N 2 Adding DMF3ml and N-trichloroacetyl N-butyl into a reaction bottle under protectionAmine (1 g), 3-amino-4, 4-trifluoro-ethyl crotonate (1.1 g) and sodium carbonate (0.54 g), stirring, heating to 130 deg.C, reacting for 3 hr, cooling, adding water and ethyl acetate, and extracting. The aqueous layer was made acidic, extracted with ethyl acetate, the organic layer was washed and concentrated to give 0.97g of product in 90% yield.
Nuclear magnetic data: 1 H NMR(500MHz,CDCl 3 )δ10.15(s,1H),6.14(s,1H),4.00–3.88(m,2H),1.68–1.55(m,4H),1.43–1.31(m,2H),0.95(t,J=7.4Hz,3H).

Claims (10)

1. a method for synthesizing 6-trifluoromethyl uracil comprises the following steps,
the method comprises the following steps: the amino compound reacts with a halogenated acetylation reagent under the action of alkali 1 to obtain a compound (I), which is represented by the following reaction formula:
Figure FDA0003039336130000011
wherein, R is 1 Is substituted or unsubstituted alkyl, substituted or unsubstituted aromatic hydrocarbon group, or nitrogen-containing heterocycle; x is halogen; y is halogen, X 3 CCOO-;
Step two: reacting the compound (I) obtained in the step one with a compound (II) in a certain solvent under the action of a base 2 to obtain a 6-trifluoromethyl uracil compound, wherein the reaction formula is as follows:
Figure FDA0003039336130000012
wherein, R is 1 And X is as defined above;
said R 2 Is a substituted or unsubstituted alkyl group.
2. The method of claim 1, wherein the base 1 is an organic base or an inorganic base; the solvent is an aprotic solvent; the alkali 2 is alkali metal carbonate or nitrogen-containing organic alkali.
3. The process of claim 1, wherein X is chlorine; the alkali 1 is alkali metal carbonate, trialkylamine and pyridine; the solvent is DMF, DMSO or xylene; the alkali 2 is potassium carbonate, sodium carbonate and DMAP.
4. The process of claim 3, wherein the base 1 is pyridine; the solvent is DMF.
5. The method according to claim 1, wherein the molar ratio of compound (II) to compound (I) is 1 to 4; the molar ratio of the base 2 to the compound (I) is 1 to 4; the reaction temperature is 110-150 ℃.
6. The process according to claim 5, wherein the molar ratio of the base 2 to the compound (I) is 2 to 3; the reaction temperature is 115-130 ℃.
7. A compound III of the formula:
Figure FDA0003039336130000021
wherein X is halogen;
R 3 is composed of
Figure FDA0003039336130000022
R 4 、R 5 、R 6 、R 7 Each independently hydrogen, substituted or unsubstituted alkyl.
8. A compound according to claim 7, wherein X is chloro.
9. The compound of claim 8, which isCharacterized in that R 3 Is composed of
Figure FDA0003039336130000023
R 5 、R 6 、R 7 Each independently hydrogen, substituted or unsubstituted alkyl.
10. The compound of claim 9, wherein compound III has the following structural formula:
Figure FDA0003039336130000024
CN202110452469.9A 2021-04-26 2021-04-26 Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof Pending CN115246791A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110452469.9A CN115246791A (en) 2021-04-26 2021-04-26 Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110452469.9A CN115246791A (en) 2021-04-26 2021-04-26 Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof

Publications (1)

Publication Number Publication Date
CN115246791A true CN115246791A (en) 2022-10-28

Family

ID=83697398

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110452469.9A Pending CN115246791A (en) 2021-04-26 2021-04-26 Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof

Country Status (1)

Country Link
CN (1) CN115246791A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1989111A (en) * 2004-07-22 2007-06-27 巴斯福股份公司 Method for the production of 3-phenyl(thio)uracils and dithiouracils
CN101821233A (en) * 2007-10-12 2010-09-01 巴斯夫欧洲公司 Method for producing sulfonic acid diamides
CN103130727A (en) * 2013-02-27 2013-06-05 江苏省农用激素工程技术研究中心有限公司 Preparation method of saflufenacil intermediate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1989111A (en) * 2004-07-22 2007-06-27 巴斯福股份公司 Method for the production of 3-phenyl(thio)uracils and dithiouracils
CN101821233A (en) * 2007-10-12 2010-09-01 巴斯夫欧洲公司 Method for producing sulfonic acid diamides
CN103130727A (en) * 2013-02-27 2013-06-05 江苏省农用激素工程技术研究中心有限公司 Preparation method of saflufenacil intermediate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIN WANG等: "New and convergent synthesis of saflufenacil", 《J HETEROCYCLIC CHEM.》, vol. 57, pages 151 - 156, XP055926461 *
万灵子等: "苯嘧磺草胺的新合成方法", 《化学通报》, vol. 82, no. 9, pages 826 - 830 *
汤阿萍等: "N -甲基-N -异丙基胺基磺酰胺的合成", 《农药》, vol. 52, no. 10, pages 721 - 722 *

Similar Documents

Publication Publication Date Title
CA2728058C (en) Process for the manufacture of an intermediate product of dabigatran etexilate
JP6802416B2 (en) Fluorine-containing pyrimidine compound and its production method
AU2010299483B2 (en) Process for the preparation of sorafenib tosylate
CN113402424A (en) Synthetic method of cyanoacrylate compound
US5342944A (en) Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones
CN101796016B (en) Novel processes and compounds
CN115246791A (en) Method for synthesizing 6-trifluoromethyl uracil and intermediate thereof
KR20080102422A (en) Method for nitrating isourea
JP4097291B2 (en) Method for producing substituted valinamide derivative
CN107690427B (en) Novel method for preparing enzalutamide
CN112778192B (en) Polyfluoroalkyl-containing isoindolinone benzamide derivatives, and preparation method and application thereof
CN113603615B (en) Preparation method of 5-halogenated-2 [ (alkoxycarbonyl) amino ] -3-methylbenzoic acid
JPH0558985A (en) Production of cyanoguanidine derivative
JPS61183258A (en) Manufacture of substituted phenylurea
JP2991832B2 (en) Method for producing pyrimidine derivative
KR100329100B1 (en) How to prepare chloromethylpyridine
US5874615A (en) Method for the preparation of insecticidal benzoylurea compounds
JPS607987B2 (en) Hydantoin derivatives
JPH0475231B2 (en)
CN113979887A (en) Synthetic method of aromatic amine carboxylic acid derivative
JPS6248667A (en) Production of thiocarbamate derivative
US20210009554A1 (en) N-alkyl-n-cyanoalkylbenzamide compound and use thereof
CN115057843A (en) Preparation method of chlorantraniliprole insecticide
CN112552243A (en) Preparation method of 2-amino-4,6-dimethoxypyrimidine
JPH01168673A (en) Production of 1,3-dialkylpyrazole-4-aldehydes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20231206

Address after: 750300 Bayin Aobao Industrial Park, Alxa League Economic and Technological Development Zone, Inner Mongolia Autonomous Region

Applicant after: INNER MONGOLIA SHIJIE CHEMICAL Co.,Ltd.

Address before: No. 618, Enterprise Service Center, Nanchong Economic Development Zone, Wenfeng Avenue, Jialing District, Nanchong City, Sichuan Province, 637000

Applicant before: Sichuan Orlando Chemical Co.,Ltd.